Antibody treatment for ovarian cancer

被引：0
|
作者：
Liddle, Rachel
机构：
来源：
LANCET ONCOLOGY | 2007年 / 8卷 / 08期
关键词：
D O I：
10.1016/S1470-2045(07)70229-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [31] CHEMOTHERAPY IN TREATMENT OF OVARIAN CANCER
    LIMBURG, HG
    PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1969, 62 (04): : 361 - &
  • [32] Ovarian cancer - Deficits in treatment
    Schmalfeldt, B
    du Bois, A
    Pfisterer, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2006, 66 (03) : 306 - 308
  • [33] Treatment advances in ovarian cancer
    Almadrones, LA
    CANCER NURSING, 2003, 26 (06) : 16S - 20S
  • [34] Diagnosis and treatment of ovarian cancer
    Kanzow, M.
    van Mackelenbergh, M.
    Maass, N.
    Bauerschlag, D.
    ONKOLOGE, 2018, 24 (04): : 343 - 356
  • [35] Treatment Options for Ovarian Cancer
    Marme, Frederik
    ONKOLOGE, 2019, 25 (02): : 90 - 91
  • [36] Niraparib for the treatment of ovarian cancer
    Kanjanapan, Yada
    Lheureux, Stephanie
    Oza, Amit M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (06) : 631 - 640
  • [37] Olaparib for the treatment of ovarian cancer
    Lheureux, Stephanie
    Oza, Amit M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 497 - 508
  • [38] Ovarian Cancer Diagnosis and Treatment
    Burges, Alexander
    Schmalfeldt, Barbara
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (38): : 635 - 641
  • [39] Olaparib in the treatment of ovarian cancer
    Washington, Christina R.
    Richardson, Debra L.
    Moore, Kathleen N.
    FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
  • [40] Treatment of recurrent ovarian cancer
    Pignata, S.
    Cecere, S. C.
    Du Bois, A.
    Harter, P.
    Heitz, F.
    ANNALS OF ONCOLOGY, 2017, 28 : 51 - 56
12345